NUCALA mepolizumab 100 mg solution for injection in pre-filled pen

GlaxoSmithKline Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 84bc831370921a02
Product Name: NUCALA mepolizumab 100 mg solution for injection in pre-filled pen
Artg Id: 317304
Artg Name: NUCALA mepolizumab 100 mg solution for injection in pre-filled pen
Sponsor: GlaxoSmithKline Australia Pty Ltd
Company Detail Path: /organization/glaxosmithkline-australia-pty-ltd
Artg Date: 2019-12-02
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/d23c3eff337720caeb7f4f6542cacf32.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/04906f70cfc32fcd71bb0d2e80b0368e.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

84bc831370921a02

Type

Standard